Skip to main navigation
Skip to search
Skip to main content
Icahn School of Medicine at Mount Sinai Home
Help & FAQ
Link opens in a new tab
Search content at Icahn School of Medicine at Mount Sinai
Home
Profiles
Research units
Publications & Research Outputs
Press/Media
Fluoropyrimidine-associated cardiotoxicity: Revisited
M. Wasif Saif
, Manasi M. Shah
, Anuj R. Shah
Research output
:
Contribution to journal
›
Review article
›
peer-review
258
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Fluoropyrimidine-associated cardiotoxicity: Revisited'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Fluoropyrimidine
100%
5-fluorouracil (5-FU)
100%
Cardiotoxicity
100%
Cardiac Symptoms
18%
Cardiac Risk
18%
Continuous Infusion
18%
Myocardial Infarction
9%
Radiation Therapy
9%
Tumor
9%
Same Patient
9%
Bolus
9%
Angina
9%
Close Monitoring
9%
Heart Failure
9%
Arrhythmia
9%
Head-and-neck
9%
Ischemia
9%
Cardiac Arrest
9%
Breast
9%
Cisplatin
9%
Heart Disease
9%
Gastrointestinal
9%
Alternative Therapy
9%
Route of Administration
9%
First Cycle
9%
Antianginal Therapy
9%
Leucovorin
9%
Rechallenge
9%
ST-T Changes
9%
Male-to-female Ratio
9%
Pericarditis
9%
Cardiac Enzymes
9%
Coronary Vasodilators
9%
Acute Pulmonary Edema
9%
Pharmacology, Toxicology and Pharmaceutical Science
Cardiotoxicity
100%
Fluorouracil
100%
Fluoropyrimidine
100%
Heart Infarction
9%
Congestive Heart Failure
9%
Syndrome
9%
Heart Arrhythmia
9%
Ischemia
9%
Heart Arrest
9%
Cisplatin
9%
Heart Disease
9%
Folinic Acid
9%
Lung Edema
9%
Sulfanilamide
9%
Pericarditis
9%
Coronary Vasodilating Agent
9%